ARGENE ®

Real-Time PCR assays

RESPIRATORY ARGENE ®

COVID-19 SOLUTIONS
Your needs. Your choice.
Specific SARS-CoV-2 detection or differential testing with multiple targets
SARS-COV-2 RESPI R-GENE® SARS-COV-2 R-GENE®
Simultaneous detection
NEW! in one sample of SARS-CoV-2 & 4 most
prevalent winter respiratory viruses
Specific SARS-CoV-2 detection

Nasopharyngeal swabs, Nasal swabs,

Nasopharyngeal swabs
Oropharyngeal (Throat) swabs & Saliva
Detected Targets Detected Targets
SARS-CoV-2 (N & RdRp gene) SARS-CoV-2 (N gene)
Influenza A PCR1 SARS-CoV-2 (RdRp gene)
PCR1
Influenza B Internal Control
Cell Control Sarbecovirus (E gene)
RSV A/B PCR2 Internal Control
PCR2
hMPV A/B Cell control
Ref. 423732 Ref. 423720

l Easy-to-use: All-in-one kits validated for use on the most common extraction and amplification platforms

l Reliable: Cell control for validation of sample quality

l Flexible: Parallel “à la carte” testing possible with other ARGENE® respiratory assays
l Streamlined workflow: Same protocols for all ARGENE® tests
 TECHNICAL INFORMATION
SARS-COV-2 RESPI R-GENE® SARS-COV-2 R-GENE®
Ordering information
ref. 423732 ref. 423720
All included All included
Kit content Positive controls, Negative Control, Positive controls, Negative Control, Cell control,
Cell control Internal control
11-20 / 9319929 007/GB/A / Document and/or pictures not legally binding. Modifications by bioMérieux can be made without prior notice / BIOMÉRIEUX, the BIOMÉRIEUX logo, ARGENE, easyMAG, EMAG, NUCLISENS and R-GENE are used, pending and/or registered

PCR1 (96 tests)

SARS-CoV-2 : N & RdRp genes PCR1 (120 tests)
Influenza A : M gene SARS-CoV-2 : N gene
Influenza B : M gene SARS-CoV-2 : RdRp gene
Gene target
trademarks belonging to bioMérieux, or one of its subsidiaries, or one of its companies / Any other name or trademark is the property of its respective owner. / bioMérieux S.A. 673 620 399 RCS Lyon / Printed in France / théra RCS Lyon B 398 160 242

Cell control : HPRT1 gene PCR2 (30 tests)

PCR2 (96 tests) Sarbecovirus : E gene
RSV A/B : N gene Cell control : HPRT1 gene
hMPV A/B : M gene

Number of tests 96 tests 120 tests

Nasopharyngeal swabs, nasal swabs,

Validated Specimen Nasopharyngeal swabs
oropharyngeal (throat) swabs & saliva

EMAG®, NUCLISENS® easyMAG®, MGISP-960,

EMAG®, NUCLISENS® easyMAG®, MGISP-960,
Extraction platforms  QIAsymphony SP, MagNA Pure 96,
QIAsymphony SP, MagNA Pure 96
MagNA Pure Compact

ABI 7500 Fast, ABI 7500 Fast Dx,
Amplification
QuantStudio 5, QuantStudio 5 Dx,
platforms
CFX96, LC480 System II
ABI 7500 Fast, ABI 7500 Fast Dx,
QuantStudio 5, QuantStudio 5 Dx, CFX96,
Rotor-Gene Q

Shelf Life 12 months at launch 24 months

Regulatory status For in vitro Diagnostic use (CE-IVD) For in vitro Diagnostic use (CE-IVD)

Storage conditions -15°C / -31°C -15°C / -31°C

ARGENE® RESPIRATORY RANGE

Need more answers?
Parallel “à la carte” testing
with additional ARGENE® respiratory assays
Rhino&EV/Cc R-GENE® Ref. 71-042
AdV/hBoV R-GENE® Ref. 71-043
Chla/Myco pneumo R-GENE® Ref. 71-044
HCOV/HPIV R-GENE® Ref. 71-045

SAME
Legio pneumo/Cc R-GENE® Ref. 71-046 ELUATE
BORDETELLA R-GENE® Ref. 69-011B PCR PROTOCOLS
Bordetella parapertussis R-GENE® Ref. 71-012
CE-IVD ASSAYS

For more information, contact your local bioMérieux representative.

bioMérieux S.A. • 69280 Marcy l’Étoile • France • Tel.: + 33 (0)4 78 87 20 00 • Fax: +33 (0)4 78 87 20 90
www.biomerieux.com